<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469064</url>
  </required_header>
  <id_info>
    <org_study_id>1755</org_study_id>
    <nct_id>NCT02469064</nct_id>
  </id_info>
  <brief_title>Effects of Respiratory Muscle Training in Mechanically Ventilated Adults</brief_title>
  <acronym>RMTMVA</acronym>
  <official_title>Effects of Respiratory Muscle Training in Mechanically Ventilated Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lina Sandoval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad del Valle, Colombia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundacion Clinica Valle del Lili</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion Clinica Valle del Lili</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory muscle training (RMT) is considered a therapeutic strategy to improve respiratory
      muscle strength in mechanically ventilated (MV) patients and facilitates ventilator weaning.
      RMT aims at improving strength and endurance of respiratory muscles . However, scarce
      research exists regarding evaluation of RMT in MV patients and additionally studies differ in
      methods, RMT protocols and subjects included. There are not reports about Colombian studies
      evaluating RMT effects on MV patients. The aim of this study is to evaluate the effectiveness
      of respiratory muscle training in increasing respiratory muscle strength and improving
      weaning outcomes in MV patients who required ventilatory support for more than 48 hours at an
      Intensive Care Unit of an IV level Hospital in Cali during the period 2014-2015
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who have been under mechanical ventilation for 48 hours are invited for
      participation in this study. Once participants are identified and his/her legal
      representative has decided to participate through an informed consent, subjects are randomly
      assigned to the experimental or conventional group.

      Data collection begins with registering individual information into a data collection form
      that has been designed for the study; muscle strength is measured as Maximum Inspiratory
      Pressure (MIP). Then, patients are assigned either to experimental or group control using
      opaque sealed envelopes. Stratified randomization is performed, using SEPSIS status as
      strata, and within each category randomization block size is 4 and 6 respectively. Once
      sepsis status has been established, green envelopes are opened for patients with sepsis, and
      blue envelopes are opened for patients without sepsis. Finally intervention is performed
      according to group assignment.

      Interventions

      Conventional Therapy Group Control group receives conventional intervention of
      Cardiopulmonary Physical Therapy which has been established by institutional protocols, and
      consists of Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical
      ventilation management

      Measuring Respiratory Muscle Strength

      Respiratory muscle strength is measured by Maximum inspiratory pressure (MIP) following
      American Thoracic Society (ATS) and European Respiratory Society (ERS). protocols. MIP
      measures are performed in both groups, experimental and control. To measure MIP, we ask the
      patient to do a maximum inspiration and then hold it for 5 seconds; this inspiration begins
      from functional residual capacity (FRC). We will perform 3 measures with each patient and
      register the highest value obtained, using a Manuvacuometer for this measure.

      Experimental Group

      The experimental group will receive conventional treatment plus a respiratory muscle training
      protocol. Respiratory muscle training utilizes a Threshold device (IMT from Respironics
      Inc;Murrysville, USA), this device has been validated both in healthy subjects and in chronic
      obstructive pulmonary disease (COPD) patients

      Study Setting

      This study is being conducted at the Adult Intensive Care Unit in Valle del Lili Foundation,
      a private health institution level IV, located in the south of Cali, this is a referral
      centre for the southwest of Colombia.

      Data Collection

      Instrument design and pilot study

      The researchers designed data collection tool to register data from clinical records and
      intervention, this tool is being used for both groups. The data collection tool includes
      demographic, clinical and intervention variables.

      A pilot trial in a group of patients with similar characteristics to the study sample was
      conducted and then some aspects of the data collection tool and measuring protocols were
      adjusted

      Research team and field personnel training

      Four physical therapy specialists who had more than 4 years of experience in intensive care
      were recruited as monitors and data collectors.

      In order to standardise and to determine validity of MIP measuring protocol, principal
      researcher conducted a training session with the physical therapists and then intra and
      inter-rater validity in 30 healthy subjects was established.

      The primary source of information was the data collection tool, which was filed during
      intervention with each subject. The secondary source of information is the electronic medical
      record, recorded data are reliable because they are a basis for decision making in critically
      ill patients.

      Patient recruiting and monitoring is performed by four physical therapists mentioned before.
      Data collection occurs from Monday to Sunday between 8:00 a.m. to 6:00 pm. Main researcher is
      not involved in data collection or intervention.

      The variables obtained on patient admission to the study are: type of intervention, age,
      gender, medical history, diagnosis at admission, Severity Index (Apache II), hours of
      mechanical ventilation, weaning hours, cumulative dose of sedative received, cumulative dose
      of analgesics received, cumulative dose of relaxant received, cumulative dose of steroids,
      socioeconomic status and educational level.

      The variable obtained during follow-up is: respiratory muscle strength.

      The variables obtained at the end of follow-up are: Number of sessions of respiratory muscle
      training received, mechanical ventilation time (in hours), total hours of weaning, cumulative
      dose of sedatives, cumulative dose of pain medication received, cumulative dose of steroids,
      received physical therapy, number of physical therapy sessions, pulmonary rehabilitation
      received, number of pulmonary rehabilitation sessions, Non Invasive Ventilation requirement,
      pulmonary rehabilitation number of sessions, death, reintubation requirement, reintubation
      date, number of extubated hours because of reintubation, tracheotomy, tracheotomy date,
      septic shock, date of septic shock, death, date of death, decision not to continue in the
      study (date).

      Data Quality

      A monthly checking of data collection tools is performed by the principal investigator, using
      a checklist and comparing data recorded in the tool with medical records of subjects, this
      procedure is done before transcribing information on to the study database. Additionally,
      every data collection tool is reviewed using a checklist that includes three quality
      indicators: days between follow-up completion and closing of tool, number of empty boxes,
      number of diagnoses that are inconsistent; this procedure is also a responsibility for the
      principal investigator. Monthly meetings with the study team are held to talk about recording
      faults and how to improve quality of data collection and registration.

      Database design and management

      Once the data in the data collection tools have been checked, information is registered in an
      Epi Info database and then this will be exported to STATA 12 for analysis. Data registering
      in the Epi Info database will be done after every data collection tool has been closed and
      checked by the main researcher. Data registering will be performed by a person hired and
      trained for these procedures. Database management and analysis is performed by the principal
      researcher.

      Data Analysis Plan

      Patient recruitment and following-up are described using a flowchart designed according to
      CONSORT statement 2010. A preliminary exploratory data analysis will be conducted to evaluate
      data performance and basic assumptions required to implement statistical tests (normality,
      linearity and homoscedasticity). This analysis will also allow us to identify errors and
      biases in data collected, as well as outliers and missing data.

      Sociodemographic and clinical characteristics of patients at study entry will be analysed
      descriptively according to measurement level of every variable using central tendency,
      dispersion measures, frequency tables and 95% confidence intervals. An analysis of clinical
      and sociodemographic characteristics of eligible patients who met inclusion criteria but were
      not included in the study will also be performed, as well as the reasons for not being
      included; this analysis will allow us to identify selection bias.

      Finally univariate and multivariate analysis will be performed according to study objectives.
      Analysis will be performed on an intention to treat basis for all patients.

      Respiratory Muscle Strength (MIP): Presuming that there is data normality, at univariate
      analysis, a difference between final MIP means of experimental group and control group will
      be analysed using a t-student. Differences in MIP means within every group will be analysed
      using linear regression. If normality, error independency and homoscedasticity are not met,
      we will consider data transformation for MIP variables. Once linear regression is performed a
      diagnostic test will be done to evaluate if the model represents or mimic observed data. In
      order to control for potential confusing factor an adjustment of variables will be done, we
      are considering as confusing factors: i)Cumulative medicament doses received before
      intervention, ii)Cumulative medicament doses received, iii) Time in ventilation mode before
      intervention, iv)Time in every ventilatory mode during intervention, v) Admission diagnoses.
      Additionally we will evaluate effect modification between variables mentioned before.

      Ventilation time and weaning time: we will perform univariate analysis of total weaning time
      and total ventilation time between experimental and control group using a survival analysis
      (Kaplan-Meyer). We also intend to do multivariate analysis of total weaning time and total
      ventilation time using Cox regression adjusting potential confusing factors that we
      considered with other variables. We will verify Cox model assumptions about hazard
      proportionality during following-up. Need for reintubation: We are doing univariate analysis
      of need for reintubation using a comparison of proportions with Chi-square or Fischer exact
      test. Need for reintubation Relative Risk (RR) will also be determined for patients in both
      groups (Control and Experimental). We are doing multivariate analysis for the need for
      reintubation with logistic regression adjusting for potential confusing factors mentioned
      before.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weaning Time From Mechanical Ventilation</measure>
    <time_frame>Measured by the end of the period of mechanical ventilation, an average expected time of 4 days</time_frame>
    <description>Weaning time was considered as time elapsed from beginning of pressure support mode in mechanical ventilation (Pressure support at 10 centimeters of water (cmsH2O) or less) or continuous positive pressure in the airway mode (CPAP) until patient extubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Maximum Inspiratory Pressure (MIP)</measure>
    <time_frame>Measured at baseline (baseline MIP) and right before patient extubation (finalMIP, an average of 2 hours)</time_frame>
    <description>Changes in Maximum Inspiratory Pressure (MIP) was considered as Final MIP minus baseline MIP</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Respiratory Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Respiratory Muscle Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental group receives as additional treatment respiratory muscle training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional physical therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional Cardiopulmonary Physical Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Respiratory muscle training</intervention_name>
    <description>Respiratory muscle training is done twice every day, with 3 series of 10 repetitions each, with a resting pause of two minutes between series (during resting time, patient is connected to mechanical ventilation again). We adjust initial load for respiratory muscle training as 50% of MIP. At the end of every training session, we assess dyspnea (perceived effort) using Modified Borg Scale (23). Four physical therapists are in charge of Respiratory muscle training, these therapists work at ICU and have experience with critically ill patients.</description>
    <arm_group_label>Respiratory Muscle Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiopulmonary Physical Therapy</intervention_name>
    <description>Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
    <arm_group_label>Conventional physical therapy</arm_group_label>
    <arm_group_label>Respiratory Muscle Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years at least

          -  Informed consent to participate in study by legal representative or family member

          -  First event requiring mechanical ventilation

          -  Being intubated at the study setting ( Valle del Lili Foundation) or at peripheral
             services and referred 12 hours or less after intubation

          -  Adequate gas interchange: Blood pressure of oxygen &gt; 60 mmHg with Inspired fraction of
             oxygen â‰¤ 0. 5 and positive pressure at end of expiration (PEEP) &lt; 8 cmh20

          -  Sedation level between -1 and 0 (24, 25)

          -  Hemodynamic stability: Medium arterial blood pressure &gt; 60 mmHg without vasopressors
             or requiring a minimum of vasopressor support (epinephrine &lt; 0,4 mcg/Kg/ min)

        Exclusion Criteria:

          -  Progressive neuromuscular disease such as Amyotrophic Lateral Sclerosis , Muscular
             Dystrophy, Multiple Sclerosis, Myasthenia Gravis, or other neuromuscular disorder that
             could interfere with response to inspiratory muscle training .

          -  Central nervous system disorders: severe traumatic brain injury

          -  Spinal cord injury at a level higher than T8

          -  Chest or spine skeletal disorders (scoliosis, flail chest, spine surgery) that limit
             movement of ribs and rib cage.

          -  Requirement of ventilatory support at home prior to hospitalization

          -  Presence of excessive secretions (requiring more than one suctioning procedure every
             hour).

          -  Tracheostomy

          -  Previous requirement of mechanical ventilation during this period of hospitalization

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lina M Sandoval, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundacion Valle del Lili- Universidad del Valle</affiliation>
  </overall_official>
  <reference>
    <citation>Martin AD, Smith BK, Davenport PD, Harman E, Gonzalez-Rothi RJ, Baz M, Layon AJ, Banner MJ, Caruso LJ, Deoghare H, Huang TT, Gabrielli A. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care. 2011;15(2):R84. doi: 10.1186/cc10081. Epub 2011 Mar 7.</citation>
    <PMID>21385346</PMID>
  </reference>
  <reference>
    <citation>Sprague SS, Hopkins PD. Use of inspiratory strength training to wean six patients who were ventilator-dependent. Phys Ther. 2003 Feb;83(2):171-81.</citation>
    <PMID>12564952</PMID>
  </reference>
  <reference>
    <citation>Martin AD, Davenport PD, Franceschi AC, Harman E. Use of inspiratory muscle strength training to facilitate ventilator weaning: a series of 10 consecutive patients. Chest. 2002 Jul;122(1):192-6.</citation>
    <PMID>12114357</PMID>
  </reference>
  <reference>
    <citation>Caruso P, Denari SD, Ruiz SA, Bernal KG, Manfrin GM, Friedrich C, Deheinzelin D. Inspiratory muscle training is ineffective in mechanically ventilated critically ill patients. Clinics (Sao Paulo). 2005 Dec;60(6):479-84. Epub 2005 Dec 12.</citation>
    <PMID>16358138</PMID>
  </reference>
  <reference>
    <citation>Bissett B, Leditschke IA, Green M. Specific inspiratory muscle training is safe in selected patients who are ventilator-dependent: a case series. Intensive Crit Care Nurs. 2012 Apr;28(2):98-104. doi: 10.1016/j.iccn.2012.01.003. Epub 2012 Feb 15.</citation>
    <PMID>22340987</PMID>
  </reference>
  <reference>
    <citation>Bissett B, Leditschke IA. Inspiratory muscle training to enhance weaning from mechanical ventilation. Anaesth Intensive Care. 2007 Oct;35(5):776-9.</citation>
    <PMID>17933168</PMID>
  </reference>
  <reference>
    <citation>Chang AT, Boots RJ, Henderson R, Paratz JD, Hodges PW. Case report: inspiratory muscle training in chronic critically ill patients--a report of two cases. Physiother Res Int. 2005;10(4):222-6.</citation>
    <PMID>16411617</PMID>
  </reference>
  <reference>
    <citation>American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624.</citation>
    <PMID>12186831</PMID>
  </reference>
  <reference>
    <citation>Cader SA, Vale RG, Castro JC, Bacelar SC, Biehl C, Gomes MC, Cabrer WE, Dantas EH. Inspiratory muscle training improves maximal inspiratory pressure and may assist weaning in older intubated patients: a randomised trial. J Physiother. 2010;56(3):171-7.</citation>
    <PMID>20795923</PMID>
  </reference>
  <reference>
    <citation>Chang AT, Boots RJ, Brown MG, Paratz J, Hodges PW. Reduced inspiratory muscle endurance following successful weaning from prolonged mechanical ventilation. Chest. 2005 Aug;128(2):553-9.</citation>
    <PMID>16100137</PMID>
  </reference>
  <reference>
    <citation>Condessa RL, Brauner JS, Saul AL, Baptista M, Silva AC, Vieira SR. Inspiratory muscle training did not accelerate weaning from mechanical ventilation but did improve tidal volume and maximal respiratory pressures: a randomised trial. J Physiother. 2013 Jun;59(2):101-7. doi: 10.1016/S1836-9553(13)70162-0.</citation>
    <PMID>23663795</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>June 2, 2015</study_first_submitted>
  <study_first_submitted_qc>June 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2015</study_first_posted>
  <results_first_submitted>August 11, 2017</results_first_submitted>
  <results_first_submitted_qc>March 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 2, 2018</results_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion Clinica Valle del Lili</investigator_affiliation>
    <investigator_full_name>Lina Sandoval</investigator_full_name>
    <investigator_title>Physical Therapist</investigator_title>
  </responsible_party>
  <keyword>mechanical ventilation</keyword>
  <keyword>respiratory muscle</keyword>
  <keyword>weaning</keyword>
  <keyword>training</keyword>
  <keyword>Intensive care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The recruitment period lasted seven months. The collection was performed in an Intensive Care Unit of a IV level clinic in the city of Cali</recruitment_details>
      <pre_assignment_details>126 patients were randomized, 3 of them did not comply with the protocol, being assigned to the experimental treatment and receiving conventional treatment.
No patient requested to be withdrawn from the study, and no patient had any adverse effects</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Conventional Physical Therapy</title>
          <description>Conventional Cardiopulmonary Physical Therapy
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
        </group>
        <group group_id="P2">
          <title>Respiratory Muscle Training</title>
          <description>Experimental group receives as additional treatment respiratory muscle training.
Respiratory muscle training: Respiratory muscle training is done twice every day, with 3 series of 10 repetitions each, with a resting pause of two minutes between series (during resting time, patient is connected to mechanical ventilation again). We adjust initial load for respiratory muscle training as 50% of maximum inspiratory pressure (MIP). At the end of every training session, we assess dyspnea (perceived effort) using Modified Borg Scale (23). Four physical therapists are in charge of Respiratory muscle training, these therapists work at intensive care unit (ICU) and have experience with critically ill patients.
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Request not to receive intervention.</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Respiratory Muscle Training</title>
          <description>Experimental group receives as additional treatment respiratory muscle training.
Respiratory muscle training: Respiratory muscle training is done twice every day, with 3 series of 10 repetitions each, with a resting pause of two minutes between series (during resting time, patient is connected to mechanical ventilation again). We adjust initial load for respiratory muscle training as 50% of MIP. At the end of every training session, we assess dyspnea (perceived effort) using Modified Borg Scale (23). Four physical therapists are in charge of Respiratory muscle training, these therapists work at ICU and have experience with critically ill patients.
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
        </group>
        <group group_id="B2">
          <title>Conventional Physical Therapy</title>
          <description>Conventional Cardiopulmonary Physical Therapy
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="62"/>
            <count group_id="B2" value="64"/>
            <count group_id="B3" value="126"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61" lower_limit="40" upper_limit="70"/>
                    <measurement group_id="B2" value="64" lower_limit="47" upper_limit="72"/>
                    <measurement group_id="B3" value="62" lower_limit="44" upper_limit="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Colombia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Weaning Time From Mechanical Ventilation</title>
        <description>Weaning time was considered as time elapsed from beginning of pressure support mode in mechanical ventilation (Pressure support at 10 centimeters of water (cmsH2O) or less) or continuous positive pressure in the airway mode (CPAP) until patient extubation</description>
        <time_frame>Measured by the end of the period of mechanical ventilation, an average expected time of 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respiratory Muscle Training</title>
            <description>Experimental group receives as additional treatment respiratory muscle training.
Respiratory muscle training: Respiratory muscle training is done twice every day, with 3 series of 10 repetitions each, with a resting pause of two minutes between series (during resting time, patient is connected to mechanical ventilation again). We adjust initial load for respiratory muscle training as 50% of MIP. At the end of every training session, we assess dyspnea (perceived effort) using Modified Borg Scale (23). Four physical therapists are in charge of Respiratory muscle training, these therapists work at ICU and have experience with critically ill patients.
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
          </group>
          <group group_id="O2">
            <title>Conventional Physical Therapy</title>
            <description>Conventional Cardiopulmonary Physical Therapy
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
          </group>
        </group_list>
        <measure>
          <title>Weaning Time From Mechanical Ventilation</title>
          <description>Weaning time was considered as time elapsed from beginning of pressure support mode in mechanical ventilation (Pressure support at 10 centimeters of water (cmsH2O) or less) or continuous positive pressure in the airway mode (CPAP) until patient extubation</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="0" upper_limit="72"/>
                    <measurement group_id="O2" value="5" lower_limit="0" upper_limit="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <method>Mann Whitneey</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.55</ci_lower_limit>
            <ci_upper_limit>1.20</ci_upper_limit>
            <estimate_desc>Univariate analysis of the probability of extubation was performed using Kaplan-Meir survival analysis and the logrank test.The multivariate analysis was performed by cox regression, a simple model was performed and a final model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Maximum Inspiratory Pressure (MIP)</title>
        <description>Changes in Maximum Inspiratory Pressure (MIP) was considered as Final MIP minus baseline MIP</description>
        <time_frame>Measured at baseline (baseline MIP) and right before patient extubation (finalMIP, an average of 2 hours)</time_frame>
        <population>24 patients did not reach a measurement of the Final MIP, of them, 14 belonged to the experimental treatment group and 10 to the conventional treatment group; therefore this result was analyzed in 102 patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Respiratory Muscle Training</title>
            <description>Experimental group receives as additional treatment respiratory muscle training.
Respiratory muscle training: Respiratory muscle training is done twice every day, with 3 series of 10 repetitions each, with a resting pause of two minutes between series (during resting time, patient is connected to mechanical ventilation again). We adjust initial load for respiratory muscle training as 50% of MIP. At the end of every training session, we assess dyspnea (perceived effort) using Modified Borg Scale (23). Four physical therapists are in charge of Respiratory muscle training, these therapists work at ICU and have experience with critically ill patients.
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
          </group>
          <group group_id="O2">
            <title>Conventional Physical Therapy</title>
            <description>Conventional Cardiopulmonary Physical Therapy
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Maximum Inspiratory Pressure (MIP)</title>
          <description>Changes in Maximum Inspiratory Pressure (MIP) was considered as Final MIP minus baseline MIP</description>
          <population>24 patients did not reach a measurement of the Final MIP, of them, 14 belonged to the experimental treatment group and 10 to the conventional treatment group; therefore this result was analyzed in 102 patients.</population>
          <units>cmH20</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.43" spread="17.48"/>
                    <measurement group_id="O2" value="5.92" spread="3.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.48</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Slope</param_type>
            <param_value>0.46</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.75</ci_lower_limit>
            <ci_upper_limit>4.78</ci_upper_limit>
            <estimate_desc>The slope shows the difference between the means of the change in the MIP of the group that received the experimental treatment and the group that received the conventional treatment</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The search for adverse events was performed up to 48 hours after the patients reached the end point of follow-up.</time_frame>
      <desc>The search for adverse events was performed daily by two physiotherapists who were part of the field work, by an institutional doctor who is part of the ICU team external to the work and by the coordinator of the respiratory therapy group. In order to search for adverse events, the Standardized Operational Manual Adverse Event Reporting was designed and the adverse events that are most likely to occur in this population extracted from the Common Terminology for Adverse Events</desc>
      <group_list>
        <group group_id="E1">
          <title>Respiratory Muscle Training</title>
          <description>Experimental group receives as additional treatment respiratory muscle training.
Respiratory muscle training: Respiratory muscle training is done twice every day, with 3 series of 10 repetitions each, with a resting pause of two minutes between series (during resting time, patient is connected to mechanical ventilation again). We adjust initial load for respiratory muscle training as 50% of MIP. At the end of every training session, we assess dyspnea (perceived effort) using Modified Borg Scale (23). Four physical therapists are in charge of Respiratory muscle training, these therapists work at ICU and have experience with critically ill patients.
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
        </group>
        <group group_id="E2">
          <title>Conventional Physical Therapy</title>
          <description>Conventional Cardiopulmonary Physical Therapy
Cardiopulmonary Physical Therapy: Control group receives Cardiopulmonary Physical Therapy every 6 hours, physical therapy and mechanical ventilation management</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Lina Marcela Sandoval Moreno</name_or_title>
      <organization>Universidad del Valle</organization>
      <phone>316 478 0808</phone>
      <email>linamarce48@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

